Literature DB >> 20116822

Temperature-sensitive mutant in the vaccinia virus E6 protein produce virions that are transcriptionally inactive.

Olga Boyd1, Audra L Strahl, Carson Rodeffer, Richard C Condit, Nissin Moussatche.   

Abstract

The vaccinia virus E6R gene encodes a late protein that is packaged into virion cores. A temperature-sensitive mutant was used to study the role of this protein in viral replicative cycle. Cts52 has a P226L missense mutation in the E6R gene, shows a two-log reduction in plaque formation, but displays normal patterns of gene expression, late protein processing and DNA replication during infection. Mutant virions produced at 40 degrees C were similar in their morphology to wt virions grown at 40 degrees C. The particle to infectivity ratio was 50 times higher in purified Cts52 grown at 40 degrees C when compared to the mutant grown at permissive temperature. In vitro characterization of Cts-52 particles grown at 40 degrees C revealed no differences in protein composition or in DNA content and the mutant virions could bind and enter cells. However, core particles prepared from Cts52 grown at 40 degrees C failed to transcribe in vitro. Our results show that E6 in the virion has either a direct or an indirect role in viral transcription. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116822      PMCID: PMC2830351          DOI: 10.1016/j.virol.2010.01.010

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

Review 1.  In a nutshell: structure and assembly of the vaccinia virion.

Authors:  Richard C Condit; Nissin Moussatche; Paula Traktman
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

2.  Vaccinia as a model for membrane biogenesis.

Authors:  S Dales; E H Mosbach
Journal:  Virology       Date:  1968-08       Impact factor: 3.616

3.  Biogenesis of vaccinia: isolation of conditional lethal mutants and electron microscopic characterization of their phenotypically expressed defects.

Authors:  S Dales; V Milovanovitch; B G Pogo; S B Weintraub; T Huima; S Wilton; G McFadden
Journal:  Virology       Date:  1978-02       Impact factor: 3.616

4.  Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly.

Authors:  Cristina Risco; Juan R Rodríguez; Carmen López-Iglesias; José L Carrascosa; Mariano Esteban; Dolores Rodríguez
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei.

Authors:  N Tolonen; L Doglio; S Schleich; J Krijnse Locker
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

6.  Poxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.

Authors:  Flavio Da Fonseca; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

7.  Azathioprine inhibits vaccinia virus replication in both BSC-40 and RAG cell lines acting on different stages of virus cycle.

Authors:  Clarissa R A Damaso; Marcus F Oliveira; Susana M Massarani; Nissin Moussatché
Journal:  Virology       Date:  2002-08-15       Impact factor: 3.616

8.  Expression of the highly conserved vaccinia virus E6 protein is required for virion morphogenesis.

Authors:  Wolfgang Resch; Andrea S Weisberg; Bernard Moss
Journal:  Virology       Date:  2009-02-12       Impact factor: 3.616

9.  The vaccinia virus E8R gene product is required for formation of transcriptionally active virions.

Authors:  Sayuri E M Kato; Richard C Condit; Nissin Moussatché
Journal:  Virology       Date:  2007-07-09       Impact factor: 3.616

Review 10.  Regulation of viral transcription elongation and termination during vaccinia virus infection.

Authors:  Richard C Condit; Edward G Niles
Journal:  Biochim Biophys Acta       Date:  2002-09-13
View more
  6 in total

1.  Myxoma virus M064 is a novel member of the poxvirus C7L superfamily of host range factors that controls the kinetics of myxomatosis in European rabbits.

Authors:  Jia Liu; Sonia Wennier; Nissin Moussatche; Mary Reinhard; Richard Condit; Grant McFadden
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Vaccinia virus mutations in the L4R gene encoding a virion structural protein produce abnormal mature particles lacking a nucleocapsid.

Authors:  Desyree Murta Jesus; Nissin Moussatche; Richard C Condit
Journal:  J Virol       Date:  2014-09-24       Impact factor: 5.103

3.  The E6 protein from vaccinia virus is required for the formation of immature virions.

Authors:  Olga Boyd; Peter C Turner; Richard W Moyer; Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2010-02-08       Impact factor: 3.616

4.  The vaccinia virus E6 protein influences virion protein localization during virus assembly.

Authors:  Richard C Condit; Nissin Moussatche
Journal:  Virology       Date:  2015-04-10       Impact factor: 3.616

5.  Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4.

Authors:  Desyree Murta Jesus; Nissin Moussatche; Baron B D McFadden; Casey Paulasue Nielsen; Susan M D'Costa; Richard C Condit
Journal:  Virology       Date:  2015-03-09       Impact factor: 3.616

6.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.